Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
400 participants
OBSERVATIONAL
2024-04-29
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim 1: To characterize typical neurodevelopment as measured by i) brain volume using low-field MRI and ii) scores on behavioral assessments of early child neurodevelopment.
Aim 2: To characterize typical pre-academic school skills in early childhood as measured by tasks of visual processing, reasoning, verbal expression and school readiness.
Aim 3: To identify factors influencing child development in a community in Bahir Dar, Amhara region of Ethiopia, as measured by validated measures of maternal mental health, home environment, and childhood adversity.
Participants will complete one low-field MRI scan at enrollment, have a hemoglobin blood test, and undergo age-appropriate neurodevelopmental assessments and surveys that may include:
* WHO Global Scales for Early Development (GSED) \[ages 6 - 36 months\]
* Tasks of visual reasoning and verbal expression \[ages 48-60 months\]
* Executive Functions test using the tablet-based NIH Toolbox \[ages 48-60 months\]
* School Readiness questionnaire assessing knowledge of literacy, numeracy, early reading, crystallized knowledge, memory, and self-regulation \[ages 48-60 months\]
* Maternal report of child's motor, cognitive and socioemotional skillsChild Anthropometrics assessment
Additional assessments of the participant's family and environment will include
* Medical History questionnaire
* Family socioeconomic status
* Maternal Mental Health
* Recent Life Events and hardship
* Home Environment and Parenting UNICEF's MICs Family Care Indicators)
* Food security and feeding practices
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Changes Associated With Learning a Motor Task
NCT00076466
Neural Correlates of Tactile Prediction
NCT04844853
Maternal Cognitive Function and Neurobehavioral Development of Underprivileged Children
NCT03321591
Early Life Anemia and Children's Risk of Neurodevelopmental Disorders: National and Regional Register-based Studies
NCT06199362
Study of Neurobehavioral Outcome in Children or Adolescents With Closed Head Injuries
NCT00006128
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Infant and early childhood neurodevelopment can be impacted by a diverse array of environmental factors beginning from the earliest stages of fetal development. Premature birth, low birth weight, poor maternal health, maternal stress, inadequate maternal and infant nutrition, reduced breastfeeding, exposure to disease, environmental neurotoxicants, and environmental adversity can all shape developing brain systems and impact emerging brain cognitive and behavioral functions. However, there is a gap in our understanding of neurodevelopmental patterns in children across LMIC settings where many neurodevelopmentally impactful adversities are magnified. Increased knowledge of risk and protective factors associated with neurodevelopmental characteristics in children can support the identification of the global and regional factors that drive poor neurodevelopmental outcomes in children and help to inform interventions to improve child outcomes
The Bahir Dar Child Development (BCD) study will characterize patterns of neurodevelopment in a community sample of children in Bahir Dar, Amhara, Ethiopia using a cross-sectional design covering children aged 6 - 60 months. Neuroimaging data collected using a low-field portable MRI scanner will be coupled with neurocognitive assessments and a broad assessment of child and family medical history, nutritional status, socioeconomic standing, and other social determinants of health. These data will be harmonized and integrated with similar data collected from other regions and countries to provide a global map of development and identify important targetable factors that will improve neurodevelopmental outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A/6 months
Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI
No interventions assigned to this group
B/12 months
Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI
No interventions assigned to this group
C/18 months
Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI
No interventions assigned to this group
D/24 months
Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI
No interventions assigned to this group
E/30 months
Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI
No interventions assigned to this group
F/36 months
Measures of child development (GSED), nutrition, medical history and anthropometrics, followed by MRI
No interventions assigned to this group
G/48 months
Measures of child neurocognitive development and school readiness, nutrition, medical history, and anthropometrics followed by MRI
No interventions assigned to this group
H/60 months
Measures of child neurocognitive development and school readiness, nutrition, medical history, and anthropometrics followed by MRI
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy child without active clinical symptoms/complaints
* Child within specified age ranges for each cohort/group (+/- 2 months)
Exclusion Criteria
* Severe developmental or behavioral disorder per maternal report
* Severe illness/clinical signs or symptoms of illness based on maternal and child report (including vomiting, headache, or seizures)
* Plans to move out of catchment area in less than 1 year
6 Months
60 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Addis Continental Institute of Public Health
OTHER
New York University
OTHER
Boston Children's Hospital, Boston, MA, USA
OTHER
Brigham and Women's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anne Lee
Director Global Newborn Health
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anne C Lee, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Brigham and Women's Hospital
Yemane Berhane, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Addis Continental Institute of Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Health Center
Bahir Dar, Addis, Ethiopia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Jensen SKG, Yibeltal K, North K, Workneh F, Teklehaimanot A, Abate BH, Fasil N, Melka TL, Chin TI, Folger LV, Roy Paladhi U, Van Dyk F, Thomason ME, Grant PE, Inder T, Worku A, Berhane Y, Lee AC. Bahir Dar Child Development Cross-Sectional Study, Ethiopia: study protocol. BMJ Paediatr Open. 2025 Apr 2;9(1):e003173. doi: 10.1136/bmjpo-2024-003173.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022P002539
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.